Engie Brasil Now Trades Below the R$8.4 Billion Price of Its Own Share Sale — Here's the Level That Confirms the Bottom

In mid-July, Brazil's largest private power producer sold 274 million new shares at R$30.50 apiece, raising R$8.4 billion to buy the 40% of the 3,750-megawatt Jirau hydro plant it did not already own. Seven weeks later, the stock trades near R$29 — below the deal price, within a few percent of its 52-week low, and about a quarter under its high. Everyone who bought the follow-on is underwater. That single fact is the setup, and it deserves more scrutiny than the tape has given it.

The road down is easy to map, and it did not happen by accident. The July offering was among the biggest follow-ons in Brazil this year, and an overhang of that size rarely lifts quietly. Then came second-quarter numbers that confused the picture in both directions at once. Headline net income nearly tripled to R$1.96 billion, up 246%, on a one-time gain from prepaying part of its public-asset-use obligations — the company settled roughly R$2.2 billion of a R$4.2 billion liability and booked a net gain in the neighborhood of R$1.3 billion while permanently dropping about R$773 million a year in payments. And yet the earnings the market actually grades came in light: adjusted EPS was roughly 14% below consensus and revenue about 4% below. When a headline pops 246% and the stock still gets sold, investors default to "something is wrong." The default may be wrong.

Strip the one-off out and the operating picture is not a deterioration story. Adjusted net income rose 23% year over year to R$694 million. Adjusted EBITDA climbed to R$2.18 billion, up about 17%, on a margin above 62%. Revenue rose 13.8% to R$3.51 billion, and the customer base in Brazil's fast-growing free energy market expanded 42%. Management attributed the EPS miss to timing, financing costs, and the accounting treatment of the prepayment and the acquisition — not to business damage — and said profitability should normalize in the second half as the newly consolidated Jirau asset, which management describes as carrying a 10% real return, begins to contribute fully. The dividend that the company actually pays grew on the adjusted base: an interim of R$0.54 a share, about 55% of first-half distributable income, with the one-off gain explicitly excluded from payout. The yield on that policy is roughly 6% at the current price.

The macro backdrop cuts the same direction. Brazil's central bank started easing in March with a cautious 25-basis-point cut, and economists now expect the Selic to end 2026 around 13.75%, down from roughly 14.75%. A hydro-heavy, contracted utility is a long-duration asset: its worth is largely a function of the discount rate applied to cash flows that are already heavily hedged — 99% of 2026 output is contracted, 95% of 2027, 89% of 2028. Value the paper the way a buyer of income would: roughly 1.14 billion shares times R$29, plus about R$25 billion of net debt, against an annualized adjusted EBITDA run-rate near R$8.7 billion, works out to an enterprise value only about 6.5 to 7 times EBITDA, with several quarters of double-digit growth behind it. Aggregate sell-side targets cluster in the low R$30s — one consensus survey averages R$34.11, roughly 17% above the price — even though the same survey stamps the stock with a "Sell" label, which is its own kind of evidence for how far sentiment has swung below the deal price.

The honest part is the part that can kill the thesis. Curtailment of output reached about 20% in the quarter — 17% for wind, 26% for solar — a real drag, though a provisional measure offers compensation for curtailment between September 2023 and November 2025. The Selic is still near 14%, and if easing stalls on inflation, the multiple stays pinned and the market is not obviously wrong here. The offering added a third more shares; that dilution will not turn accretive in a single quarter. And by 2030, about 37% of output sits uncontracted, so the long-term story leans on merchant prices that are anything but guaranteed. Any of these cracking is how a contrarian call becomes a falling knife. That is why the technical picture matters as the timing layer rather than as the thesis.

The levels, then. The line that confirms a bottom is R$30.50 — the follow-on price. R$8.4 billion of stock changed hands there in July; until it is reclaimed it is overhead supply, and a decisive weekly move back above it — not a touch, a reclaim — turns that supply into the cleanest support the chart has, with the round R$30 and the R$33–34 target zone above. The line that breaks the setup is R$27.30, the August 21 low. Note the caret most traders miss: that "new 52-week low" printed on the same day the shares went ex-dividend by R$0.54 — a mechanical adjustment accounted for part of the decline, so the chart's fresh low overstates the breakdown. Below R$27.30, the next reference is the R$26.50 tail of the range, and beneath that there is no built-in floor. That is why that single level, not a guess about the macro, is the honest stop.

What the tape-oriented crowd is missing is that price and fundamentals disconnected in opposite directions. The headline said "up 246%"; the adjusted print said "missed"; both were noise around a business whose distributable income grew 23%. The offer price says the market's most recent disclosed benchmark — R$8.4 billion of institutional money — is now roughly 5% above the quote. US investors reach all of this through the 1-for-1 ADR, EGIEY, which simply tracks the local price. This is a candidate to watch, not a reason to chase: the lower-risk entries are a confirmed reclaim of R$30.50 or a retest that holds R$27.30, and the operative horizon is two to three quarters, until Jirau's contribution becomes visible in adjusted income and the direction of the easing cycle is confirmed. Until then, the yield does the waiting. If a weekly close below R$27.30 shows up first, the market was right, and the honest response is to let it be.